The Patent Finder

Achillion Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Achillion Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 51 patents it holds.

Back to Achillion Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,106,563Ether Compounds for Treatment of Complement Mediated Disorders
Lapsed on the fee record
Ended Oct 23, 2026 · Low confidence
Lapsed on the fee recordEnded Oct 23, 2026Low confidence
US 10,100,072Phosphonate Compounds for Treatment of Complement Mediated Disorders
Lapsed on the fee record
Ended Oct 16, 2026 · Low confidence
Lapsed on the fee recordEnded Oct 16, 2026Low confidence
US 10,092,547Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-Heteraphanes and Metallocenes Useful for Treating HCV Infections
Lapsed on the fee record
Ended Oct 9, 2026 · High confidence
Lapsed on the fee recordEnded Oct 9, 2026High confidence
US 10,092,584Compounds for the Treatment of Medical Disorders
Lapsed on the fee record
Ended Oct 9, 2026 · High confidence
Lapsed on the fee recordEnded Oct 9, 2026High confidence
US 10,087,203Compounds for Treatment of Complement Mediated Disorders
Lapsed on the fee record
Ended Oct 2, 2026 · High confidence
Lapsed on the fee recordEnded Oct 2, 2026High confidence
US 8,809,313Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-Heteraphanes and Metallocenes Useful for Treating HCV Infections
Lapsed on the fee record
Ended Aug 19, 2026 · High confidence
Lapsed on the fee recordEnded Aug 19, 2026High confidence
US 8,946,4228-Methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and Related Compounds as Anti-Infective Agents
Term ended
Ended no later than Jul 27, 2026 · Low confidence
Term endedEnded no later than Jul 27, 2026Low confidence
US 8,785,378Macrocyclic Peptides as Inhibitors of Viral Replication
Lapsed on the fee record
Ended Jul 22, 2026 · High confidence
Lapsed on the fee recordEnded Jul 22, 2026High confidence
US 10,005,802Amide Compounds for Treatment of Complement Mediated Disorders
Lapsed on the fee record
Ended Jun 26, 2026 · Medium confidence
Lapsed on the fee recordEnded Jun 26, 2026Medium confidence
US 10,000,516Phosphonate compounds for treatment of medical disorders
Lapsed on the fee record
Ended Jun 19, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 19, 2026USPTO record
10 of 55 patents shown.
Pro members see all 55.
Pro members: see all 55 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited